ResMed Inc

It primarily provides cloud-connectable CPAP devices and masks for the treatment of sleep apnea, as well as devices and masks for treating chronic obstructive pulmonary disease (COPD), neuromuscular disease, and other respiratory-related conditions. It also provides a self-monitoring digital sensor and app for people who use inhalers to treat COPD or asthma via Propeller Health, which ResMed acquired in 2019.

In addition to its Sleep and Respiratory Care business, ResMed also provides software as a service (SaaS) to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers (i.e. home medical equipment, home health, home infusion pharmacy, hospice, skilled nursing facilities, life plan communities, senior living, and private duty). ResMed's SaaS business includes Brightree, which ResMed acquired in 2016, and MatrixCare and HEALTHCAREfirst, both acquired in 2018.

ResMed is closely monitoring and responding to the COVID-19 pandemic; the health and safety of our people, customers, business partners; and those who use our products and solutions worldwide is our top priority.

ResMed making a positive impact on millions of lives every day in more than 140 countries. We’re passionate about being accountable to the communities we’re in. Our work is guided by an environmental policy that promotes waste and pollution reduction, the use of reduced-impact materials and fair labor practices across the globe. Our strategy is to change the lives of 250 million people in 2025.